Healthcare Market Research Reports

The global adaptive radiotherapy market is valued at $1.75 billion in 2025 and is projected to reach $3.60 billion by 2030, expanding at a compound annual growth rate of 15.5% across the forecast period. This trajectory sits well above the growth rate of the broader radiotherapy industry, a gap that signals a structural shift rather than incremental improvement.

The global infectious disease in vitro diagnostics market is entering a phase of steady, service-driven expansion rather than the crisis-fueled surges that defined the pandemic years. Valued at an estimated $26.5 billion in 2025, the market is projected to reach approximately $30.0 billion by 2030, advancing at a compound annual growth rate of 2.5% across the forecast window.

The global isokinetic rehabilitation and strength assessment systems market is valued at $610 million in 2025 and is projected to reach $865 million by 2030, expanding at a 7.2% CAGR across the 2026-2030 forecast period. Growth is anchored in three structural forces: rising sports-related injury caseloads among both amateur and professional athletes, an aging population that increasingly requires

Guided Biofilm Therapy, commonly abbreviated as GBT, is a standardized clinical protocol that combines biofilm detection, air polishing with low-abrasive powders, and selective ultrasonic debridement into a single, repeatable workflow for removing dental biofilm and calculus. Rather than defaulting to traditional hand-scaling as the first line of treatment, GBT reorders the sequence of care around

The global Actinium-225 radiopharmaceutical supply and targeted alpha therapy market is valued at USD 685 million in 2025 and is projected to reach USD 1,540 million by 2030, expanding at a compound annual growth rate of 17.6% across the forecast period.

Spatial mass spectrometry imaging has moved from a specialized academic technique to a core capability inside pharmaceutical discovery, translational research, and precision oncology programs. The technology fuses mass spectrometry's molecular specificity with pixel-by-pixel spatial mapping, letting scientists see where a drug, lipid, protein, or metabolite sits inside a tissue section rather

The North America Medicare Advantage platform market is moving through a rare convergence of pressures landing on health plans in the same budget cycle: enrollment growth, margin compression, and a wave of CMS-driven technology mandates. Valued at $3.05 billion in 2025, the market is projected to reach $4.78 billion by 2030, expanding at a 9.4% compound annual growth rate across the 2026–203

The global Guided Biofilm Therapy (GBT) market is valued at an estimated $1,050 million in 2025 and is projected to reach approximately $1,705 million by 2030, expanding at a CAGR of around 10.2% over the forecast period. Growth is being driven by the shift toward minimally invasive periodontal and peri-implant maintenance, the standardization of biofilm-management protocols across dental service

Structural heart programs worldwide are treating a growing volume of valvular stenosis cases with catheter-based tools rather than open surgery, and valvuloplasty balloon catheters sit at the center of that shift. The global valvuloplasty balloon catheters market is valued in the low single-digit billions in 2025 and is on a steady growth path through 2030, propelled by an aging population, expand

The global clinical trial statistical programming services market is valued at $1.85 billion in 2025 and is projected to reach $2.95 billion by 2030, expanding at a 9.8% compound annual rate. Growth is concentrated in a narrow set of structural shifts that are reshaping how sponsors and CROs staff, budget for, and contract this work.